Organization
Anhui Provincial Cancer Hospital
3 clinical trials
7 abstracts
Abstract
Golidocitinib in treating refractory or relapsed peripheral T-cell lymphoma: Primary analysis of the multinational pivotal study results (JACKPOT8).Org: Sun Yat-sen University Cancer Center (China), Rui Jin Hospital Affiliated to Shanghai Jiao Tong University, Jinagsu Province Institute of Cancer Research, The University of Texas MD Anderson Cancer Center, Chongqing University Cancer Hospital,
Abstract
Efficacy and safety of cadonilimab in combination with pulocimab and paclitaxel as second-line therapy in patients with advanced gastric or gastroesophageal junction (G/GEJ) cancer who failed immunochemotherapy: A multicenter, double-blind, randomized trial.Org: Department of Gastrointestinal Oncology, Peking University Cancer Hospital and Institute, Beijing, China, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China, Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Liaoning Cancer Hospital and Institute, Shenyang, China,
Clinical trial
Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer: A Single-arm, Single-center, Exploratory Clinical StudyStatus: Recruiting, Estimated PCD: 2025-05-01
Clinical trial
Sorafenib Combined With Carboplatin/Paclitaxel and Sorafenib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer: a Single-arm, Multicenter, Exploratory Clinical StudyStatus: Recruiting, Estimated PCD: 2025-10-30
Abstract
Effectiveness and safety of camrelizumab in advanced esophageal cancer: A prospective multicenter observational cohort studies (ESCORT-RWS).Org: Peking University Cancer Hospital and Institute (Beijing Cancer Hospital), Beijing, China, Beijing InnoCare Pharma Tech, China National Biotec Group, Changzhi People's Hospital Affiliated to Changzhi Medical College, Changzhi City,
Abstract
A retrospective study on the efficacy and safety of avatrombopag in the treatment of chemotherapy-induced thrombocytopenia in gastrointestinal cancer.Org: Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy, Italy, Sun Yat-sen University Cancer Center Gansu Hospital, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China, Collaborative Innovation Center for Cancer Medicine, Guangzhou JOYO Pharma,
Abstract
A phase IV study to evaluate the safety of fruquintinib in Chinese real-world clinical practice.Org: Tongji University Shanghai East Hospital, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center Gansu Hospital, Zhejiang Cancer Hospital, Chinese Academy of Sciences,
Abstract
Efficacy and safety of camrelizumab combined with apatinib in the treatment of advanced gastric cancer: Preliminary results from a multicenter, prospective study.Org: The First Affiliated Hospital of University of Science and Technology of China, Chaohu Hospital of Anhui Medical University, People's Liberation Army Navy Anqing Hospital, The Second Hospital of Anhui Medical University, Hefei, China, Anhui No.2 Provincial People's Hospital,
Abstract
Denosumab biosimilar (LY01011) in the treatment of bone metastases in patients with solid tumors: A multicenter, randomized, double-blind, active comparator-controlled phase 3 study.Org: Fudan University Shanghai Cancer Center, Guangxi Tumor Hospital, Department of Medical Oncology, Harbin Medical University Cancer Hospital, First Affiliated Hospital of Gannan Medical University, Department of Oncology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China,
Clinical trial
An Exploratory Clinical Study of Statins for Improving Chemotherapy and Maintenance in Patients With Ovarian Cancer: a Prospective, Multicenter Clinical StudyStatus: Recruiting, Estimated PCD: 2025-05-30